First anti-BCMA therapy to be approved anywhere in the world

Study co-led by UCL and the London School of Hygiene & Tropical Medicine

Allergy drug approved for severe chronic rhinosinusitis with nasal polyps

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Creative chemists employ enzymes to build a complex but promising natural anti-cancer agent called cepafungin I in a […]

House Dems launch probe into Kodak’s unexpected $765M drug manufacturing loan from the feds aliu Thu, 08/06/2020 – […]